Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Oncotargets and Therapy
|
April 5, 2016
Tremelimumab: research and clinical development
Begoña Comin-Anduix, Helena Escuin-Ordinas, Francisco Javier Ibarrondo
Biotechnology & Genetic Engineering Reviews
|
March 19, 2011
2A to the fore - research, technology and applications
Garry Luke, Helena Escuin, Pablo De Felipe, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 12, 2018
Accelerated wound healing by injectable star poly(ethylene glycol)-b-poly(propylene sulfide) scaffolds loaded with poorly water-soluble drugs
Suwei Zhu, Shuoran Li, Helena Escuin-Ordinas, et al.
Nucleic Acids Research
|
December 6, 2011
2A peptides provide distinct solutions to driving stop-carry on translational recoding
Pamila Sharma, Fu Yan, Victoria A Doronina, et al.
Molecular Biology and Evolution
|
June 4, 2013
APE-type non-LTR retrotransposons of multicellular organisms encode virus-like 2A oligopeptide sequences, which mediate translational recoding during protein synthesis
Valerie Odon, Garry A Luke, Claire Roulston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2010
The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations
Begoña Comin-Anduix, Thinle Chodon, Hooman Sazegar, et al.
Cancer Research
|
November 18, 2015
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
Richard Tavaré, Helena Escuin-Ordinas, Stephen Mok, et al.
Plos One
|
September 22, 2010
Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma
Begoña Comin-Anduix, Hooman Sazegar, Thinle Chodon, et al.
Molecular Cancer
|
February 4, 2015
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Mohammad Atefi, Bjoern Titz, Earl Avramis, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2014
PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody
Helena Escuin-Ordinas, Mark W Elliott, Mohammad Atefi, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Oncotargets and Therapy
|
April 5, 2016
Tremelimumab: research and clinical development
Begoña Comin-Anduix, Helena Escuin-Ordinas, Francisco Javier Ibarrondo
Biotechnology & Genetic Engineering Reviews
|
March 19, 2011
2A to the fore - research, technology and applications
Garry Luke, Helena Escuin, Pablo De Felipe, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 12, 2018
Accelerated wound healing by injectable star poly(ethylene glycol)-b-poly(propylene sulfide) scaffolds loaded with poorly water-soluble drugs
Suwei Zhu, Shuoran Li, Helena Escuin-Ordinas, et al.
Nucleic Acids Research
|
December 6, 2011
2A peptides provide distinct solutions to driving stop-carry on translational recoding
Pamila Sharma, Fu Yan, Victoria A Doronina, et al.
Molecular Biology and Evolution
|
June 4, 2013
APE-type non-LTR retrotransposons of multicellular organisms encode virus-like 2A oligopeptide sequences, which mediate translational recoding during protein synthesis
Valerie Odon, Garry A Luke, Claire Roulston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2010
The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations
Begoña Comin-Anduix, Thinle Chodon, Hooman Sazegar, et al.
Cancer Research
|
November 18, 2015
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
Richard Tavaré, Helena Escuin-Ordinas, Stephen Mok, et al.
Plos One
|
September 22, 2010
Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma
Begoña Comin-Anduix, Hooman Sazegar, Thinle Chodon, et al.
Molecular Cancer
|
February 4, 2015
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
Mohammad Atefi, Bjoern Titz, Earl Avramis, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2014
PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody
Helena Escuin-Ordinas, Mark W Elliott, Mohammad Atefi, et al.
Page
of 3